Financial & competing interests disclosure
AM Rapoport is on the speaker’s bureau of Allergan, Nautilus Neurosciences and Zogenix. He is a Consultant to Allergan, Nautilus Neurosciences, MAP, NuPathe, Winston and Zogenix. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.